Deerfield Mgmt L.P.
SEC CIK 1010823 · EDGAR
BoughtSold
Most active insiders at LRMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Deerfield Mgmt HIF, L.P. | Dir, 10%, * Dir by Deputization | $25.00M | — |
| 2 | Hamilton Thomas Edward | Dir | $666.9K | — |
| 3 | THOMAS FRANK E | Dir | $25.0K | — |
| 4 | SHERMAN JEFFREY W | Dir | $25.0K | — |
| 5 | Shankar Gopi | Chief Development Off | — | — |
| 6 | Clayton Russell | Chief Medical Off | — | — |
| 7 | BEN-MAIMON CAROLE | Pres, CEO, Dir | — | — |
| 8 | Celano Michael | CFO | — | — |
Deerfield Mgmt L.P. made no open-market trades at LRMR in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-02-16 | 2024-02-16 | LRMR | Larimar Therapeutics, Inc. | Deerfield Mgmt L.P. | Dir, 10%, * Dir by Deputization | P - Purchase | $8.74 | +4.29M | 4.21M | New | +$37.50M |
| DMI | 2021-10-28 | 2021-10-26 | XLO | Xilio Therapeutics, Inc. | Deerfield Mgmt L.P. | 10%, Possible Member of 10% Group | P - Purchase | $16.00 | +775.0K | 1.14M | +210% | +$12.40M |
| DMI | 2021-10-28 | 2021-10-26 | XLO | Xilio Therapeutics, Inc. | Deerfield Mgmt L.P. | 10%, Possible Member of 10% Group | C - Cnv Deriv | — | +1.51M | 756.5K | New | — |
Purchase Sale Sale after option exercise All abbreviations